In the face of the relentless threat posed by highly pathogenic RNA viruses, such as SARS-CoV-2, HIV, and avian influenza, the quest for innovative antiviral therapies has never been more urgent.
The 4th RNA-Targeted Drug Discovery Summit is returning once again this December, to reunite the largest community of thought leaders and experts in biology, chemistry and RNA therapeutics to ...